Search
for
Sort by
Research 751–780 of 1000+
- 5α-Reduced glucocorticoids: a story of natural selection
- The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair
- Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial
- Ketoconazole Therapy for Women with Acne and/or Hirsutism
- Estrogen-Androgen Imbalance in Patients with Hirsutism and Amenorrhea
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Hair melanocytes as neuro-endocrine sensors—Pigments for our imagination
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Toward a Diagnostic Score in Cushing's Syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- A Detailed Investigation of Hirsutism in a Turkish Population: Idiopathic Hyperandrogenemia as a Perplexing Issue
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis
- Metabolic Syndrome and Skin Diseases
- Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- An Update on Plant Derived Anti-Androgens
- Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors
- MK-386, an Inhibitor of 5α-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in Semen<sup>1</sup>
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Two New Unrelated Cases of Hereditary 1,25-Dihydroxyvitamin D-resistant Rickets with Alopecia resulting from the same Novel Nonsense Mutation in the Vitamin D Receptor Gene
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome